NDD Europe 2019 took place in Paris, France on May 22-23. The meeting was focused on neurodegenerative diseases and provided members of the drug development community with an opportunity to discuss how to overcome the translational challenges in the development of clinically disease-modifying therapeutics.
If you are interested in learning more about Cellectricon’s drug discovery services you are very welcome to reach out and schedule a meeting with us.